Scaling up treatment for the global AIDS pandemic : challenges and opportunities
著者
書誌事項
Scaling up treatment for the global AIDS pandemic : challenges and opportunities
National Academies Press, c2005
- : pbk
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references
HTTP:URL=http://www.loc.gov/catdir/toc/ecip052/2004023710.html Information=Table of contents
内容説明・目次
内容説明
An estimated forty million people carry the human immunodeficiency virus (HIV), and five million more become newly infected annually. In recent years, many HIV-infected patients in wealthy nations have enjoyed significantly longer, good-quality lives as a result of antiretroviral therapy (ART). However, most infected individuals live in the poorest regions of the world, where ART is virtually nonexistent. The consequent death toll in these regions?especially sub-Saharan Africa?is begetting economic and social collapse.
To inform the multiple efforts underway to deploy antiretroviral drugs in resource-poor settings, the Institute of Medicine committee was asked to conduct an independent review and assessment of rapid scale-up ART programs. It was also asked to identify the components of effective implementation programs.
At the heart of the committee's report lie five imperatives:
Immediately introduce and scale up ART programs in resource-poor settings.
Devise strategies to ensure high levels of patient adherence to complicated treatment regimens.
Rapidly address human-resource shortages to avoid the failure of program implementation.
Continuously monitor and evaluate the programs to form the most effective guidelines and treatment regimens for each population.
Prepare to sustain ART for decades.
Table of Contents
Front Matter
Executive Summary
1 Introduction
2 Opportunities and Challenges
3 Lessons Learned
4 Principles of Scale-Up
5 Managing Scale-Up of Antiretroviral Therapy
6 The Path Forward
Appendix A: Information Gathering Workshop Agenda
Appendix B: Primer on Humanimmunodeficiency Virus, Acquired Immune
Deficiency Syndrome and Antiretroviral Therapy
Appendix C: Scaling Up Antiretroviral Therapy in Resource-Limited
Settings: Treatment Guidelines for a Public Health Approach
Appendix D: Human Ethical Issues Arising in ARV Scale-Up in
Resource Constrained Settings
Appendix E: Human Resource Requirements for Scaling Up
Antiretroviral Therapy in Low-Resource Countries
Appendix F: Glossary and Acronyms
Appendix G: Committee and Staff Biographies
目次
- 1 Front Matter
- 2 Executive Summary
- 3 1 Introduction
- 4 2 Opportunities and Challenges
- 5 3 Lessons Learned
- 6 4 Principles of Scale-Up
- 7 5 Managing Scale-Up of Antiretroviral Therapy
- 8 6 The Path Forward
- 9 Appendix A: Information Gathering Workshop Agenda
- 10 Appendix B: Primer on Humanimmunodeficiency Virus, Acquired Immune Deficiency Syndrome and Antiretroviral Therapy
- 11 Appendix C: Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach
- 12 Appendix D: Human Ethical Issues Arising in ARV Scale-Up in Resource Constrained Settings
- 13 Appendix E: Human Resource Requirements for Scaling Up Antiretroviral Therapy in Low-Resource Countries
- 14 Appendix F: Glossary and Acronyms
- 15 Appendix G: Committee and Staff Biographies
「Nielsen BookData」 より